SPTAN1 and lung cancer: Besides the downregulation of SPTAN1 in lung cancer compared to normal tissue, Sun et al. described conserved recurrent gene mutations in both the SPTAN1 gene and mRNA, which were highly correlated with pathway deregulation and worse survival [34].